| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,361 |
5,161 |
$138K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,551 |
2,582 |
$50K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,988 |
2,585 |
$40K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
595 |
403 |
$19K |
| 71046 |
Radiologic examination, chest; 2 views |
1,819 |
1,361 |
$11K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
456 |
413 |
$9K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
299 |
267 |
$7K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,642 |
1,329 |
$7K |
| 80053 |
Comprehensive metabolic panel |
8,123 |
6,502 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,365 |
1,853 |
$5K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,854 |
7,004 |
$4K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,525 |
925 |
$4K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
481 |
413 |
$3K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
947 |
327 |
$3K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,007 |
696 |
$3K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,919 |
2,352 |
$3K |
| 70450 |
Computed tomography, head or brain; without contrast material |
227 |
167 |
$3K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
101 |
95 |
$2K |
| G0378 |
Hospital observation service, per hour |
117 |
89 |
$2K |
| 81001 |
|
3,335 |
2,800 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
13,736 |
10,098 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,804 |
1,241 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,368 |
1,122 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,249 |
998 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,107 |
896 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
427 |
302 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,709 |
1,325 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
352 |
319 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
248 |
114 |
$997.49 |
| 83605 |
|
928 |
702 |
$972.36 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
286 |
257 |
$914.48 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
839 |
746 |
$879.55 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
119 |
112 |
$819.02 |
| 83690 |
|
1,179 |
979 |
$807.16 |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,702 |
2,459 |
$804.08 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,576 |
1,154 |
$801.03 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
116 |
108 |
$728.29 |
| 97161 |
|
289 |
259 |
$725.42 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
308 |
247 |
$692.27 |
| 73610 |
|
50 |
38 |
$680.06 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,865 |
1,485 |
$663.30 |
| 87486 |
|
275 |
245 |
$661.43 |
| 87581 |
|
275 |
245 |
$661.43 |
| 84484 |
|
1,328 |
846 |
$604.47 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
519 |
333 |
$581.30 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,801 |
1,235 |
$524.83 |
| 87430 |
|
219 |
200 |
$521.73 |
| 86140 |
|
274 |
210 |
$486.62 |
| J2704 |
Injection, propofol, 10 mg |
567 |
494 |
$455.20 |
| 73630 |
|
107 |
78 |
$414.51 |
| 80306 |
|
218 |
191 |
$382.63 |
| 85027 |
|
1,335 |
1,097 |
$357.73 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
223 |
169 |
$341.27 |
| 84703 |
|
140 |
121 |
$268.55 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
181 |
148 |
$212.96 |
| 87081 |
|
177 |
163 |
$208.97 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
85 |
39 |
$173.70 |
| 82728 |
|
221 |
204 |
$164.13 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
335 |
314 |
$152.67 |
| 81025 |
|
46 |
43 |
$148.83 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
44 |
35 |
$141.28 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
563 |
489 |
$131.61 |
| 80061 |
Lipid panel |
1,296 |
1,227 |
$69.24 |
| 85651 |
|
56 |
49 |
$64.96 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,993 |
1,831 |
$50.34 |
| 83550 |
|
87 |
79 |
$29.98 |
| 82607 |
|
102 |
95 |
$26.06 |
| 83540 |
|
105 |
95 |
$22.20 |
| 82077 |
|
14 |
12 |
$20.33 |
| 85652 |
|
29 |
24 |
$9.26 |
| 82570 |
|
27 |
25 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,238 |
1,148 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
112 |
50 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
95 |
75 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
139 |
113 |
$0.00 |
| 85610 |
|
226 |
149 |
$0.00 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
51 |
38 |
$0.00 |
| 84145 |
|
24 |
15 |
$0.00 |
| 87186 |
|
27 |
25 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
30 |
12 |
$0.00 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
736 |
314 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,234 |
965 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
115 |
96 |
$0.00 |
| 83735 |
|
56 |
49 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,556 |
679 |
$0.00 |
| Q3014 |
Telehealth originating site facility fee |
58 |
53 |
$0.00 |
| 85379 |
|
91 |
73 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
122 |
101 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
58 |
24 |
$0.00 |
| 87077 |
|
59 |
50 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
55 |
44 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
68 |
52 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
31 |
14 |
$0.00 |
| A9270 |
Non-covered item or service |
35 |
13 |
$0.00 |
| 82746 |
|
30 |
28 |
$0.00 |
| 97113 |
|
89 |
26 |
$0.00 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
20 |
12 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
19 |
16 |
$0.00 |